$Shanghai Fosun Pharmaceutical (600196.SH)$ Fosun's decline ...

$Shanghai Fosun Pharmaceutical (600196.SH)$ Fosun's decline comes from domestic protection of domestically produced vaccines and control of foreign vaccines. Investors who don't know the truth think that the Forbitel vaccine cannot enter the mainland, so withdrawing funds is a major mistake. Domestically produced MRNA is only Watson. Leaving aside the gap between domestic R&D and manufacturing processes, the current planned annual output of 200 million units is only enough to meet the needs of 100 million people, and there is also a need for external supply and foreign aid. However, traditional vaccines have proved that it is simply impossible to help China achieve immunity through vaccines. Although patriotism is what the government wants, the reality is very cruel. Refusing an effective vaccine or excessive self-isolation is more important, and absolute authority must also face the impact of the epidemic. We are optimistic that Fubitai will enter China for a long time, because China's population is too large to meet the needs of 100 million people, and the virus will not disappear in the short term